Keith A Goldan's Net Worth
Keith A Goldan's net worth is estimated to be at least $233,119.73 as of 02/15/2026. CoreStreet's estimation of Keith A Goldan's net worth is based on their sale of stock and current holding of stock.
Keith A Goldan is CFO at Syndax Pharmaceuticals Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 3,410 units of SNDX stock on 02/09/2026. Their biggest sale was on 02/09/2026 when they sold 3,410 units of Syndax Pharmaceuticals Inc stock for $71,712.30. They typically trade 1 times per year.
Total value of insider buys:
- $25,037.50
Total value of insider sells:
- $208,082.23
Most recent insider trade:
- Feb. 9, 2026
Keith A Goldan's Insider Trading History
| Syndax Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 9, 2026 | CFO | 3,410 | $21.03 | Sell | $71,712.30 |
Feb. 6, 2026 | CFO | 2,082 | $20.62 | Sell | $42,930.84 |
July 16, 2025 | CFO | 1,296 | $9.29 | Sell | $12,039.84 |
Feb. 10, 2025 | CFO | 3,777 | $15.50 | Sell | $58,543.50 |
June 14, 2024 | CFO | 1,250 | $20.03 | Buy | $25,037.50 |
June 13, 2023 | CFO | 577 | $22.31 | Sell | $12,872.87 |
| OptiNose | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 16, 2021 | CFO | 580 | $1.64 | Sell | $951.20 |
March 15, 2021 | CFO | 2,304 | $3.92 | Sell | $9,031.68 |